Preventing Renal Functional Abnormalities With Calorie Restriction in Subjects With Abdominal Obesity and Type 2 Diabetes at Increased Renal and Cardiovascular Risk
NCT01213212 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 73
Last updated 2013-02-21
Summary
The study investigates whether a caloric restricted dietary regime can prevent onset and/or progression of chronic kidney disease in type 2 diabetic patients with abdominal obesity, through the amelioration of concomitant metabolic abnormalities such as insulin resistance, dyslipidemia, hypertension and inflammation, possible risk factors for the onset of kidney disease.
The main aim of the study is therefore to evaluate the renoprotective effect of caloric restriction (CR) on subjects at risk of nephropathy. Secondary aim is to better understand how dietary implementation can modulate renal disease and its associated metabolic abnormalities.
Conditions
Interventions
- OTHER
-
Caloric restriction
Caloric restriction.
- OTHER
-
No intervention
Diet "ad libitum"
Sponsors & Collaborators
-
Istituto Superiore di Sanità
collaborator OTHER -
Mario Negri Institute for Pharmacological Research
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 40 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-09-30
- Primary Completion
- 2012-12-31
- Completion
- 2013-02-28
Countries
- Italy
Study Locations
More Related Trials
-
Mechanisms Underlying SGLT2i Kidney Effect in DKD Progression
NCT07270198 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Observational Study to Evaluate the Relationship Between Ketonemia and Renal Function in the Diabetic Patient
NCT03859817 ·Status: UNKNOWN
-
Effect of Adipokines in Hemodialysis Patients
NCT01301027 ·Status: COMPLETED ·Phase: NA
-
Impact of Dapagliflozin on Intestinal Microbiota Composition and on the Metabolites Derived From the Intestinal Microbiota in Non-diabetic Chronic Renal Failure Patients
NCT05965440 ·Status: COMPLETED ·Phase: NA
-
Renal Impairment in Type 2 Diabetic Subjects
NCT00554450 ·Status: COMPLETED ·Phase: PHASE1
-
SeMaglutide and Albuminuria Reduction Trial in Obese Individuals Without Diabetes
NCT04889183 ·Status: COMPLETED ·Phase: PHASE3
-
Obesity Treatment to Improve Diabetes
NCT05390307 ·Status: COMPLETED ·Phase: NA
-
A Research Study Looking Into Blood Levels of NNC0174-0833 in People With Normal and Impaired Kidney Function
NCT04209049 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Integrated CKD Care Program in Early Diabetic Nephropathy in Primary Health Care Setting.
NCT02194790 ·Status: COMPLETED ·Phase: NA
-
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
NCT01621178 ·Status: COMPLETED ·Phase: PHASE3
-
GLUcose Transport and REnalPROtection in Chronic Kidney Disease
NCT05998837 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Incretin Effect in Patients With Kidney Impairment
NCT01327378 ·Status: COMPLETED
-
OPTIMISE-CKD Drug Utilization
NCT05932901 ·Status: COMPLETED
-
Survey of Patient and Physician Awareness and Values to the Diagnosis and Treatment of Reduced Kidney Function (Chronic Kidney Disease) in Patients With High Blood Sugar Level (Type 2 Diabetes) (AWARE-CKD in T2D)
NCT04498156 ·Status: COMPLETED
-
Semaglutide's Effect on Renal Hemodynamics and Function in Patients With Type 2 Diabetes Mellitus and Nephropathy
NCT06555146 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Metabolic and Renal Effects of Rosiglitazone in Kidney Transplant
NCT00309309 ·Status: COMPLETED ·Phase: PHASE2
-
Renoprotective Effects of Dapagliflozin in Type 2 Diabetes
NCT02682563 ·Status: COMPLETED ·Phase: PHASE4
-
Intensive Medical Treatment for Nephropathy Caused by Type 2 Diabetes With Hypertension
NCT00407680 ·Status: UNKNOWN ·Phase: PHASE4
-
Renal Insufficiency And Cardiovascular Events
NCT00715481 ·Status: COMPLETED
-
Diabetic Patients With End-Stage Renal Disease
NCT00435786 ·Status: COMPLETED
-
Acute Kidney Injury in Patients on Dapagliflozin and Other Antidiabetic Medications
NCT02695082 ·Status: COMPLETED
-
Renoprotective Effects of Dulaglutide in Patients With Type 2 Diabetic Nephropathy
NCT06182891 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy
NCT02065791 ·Status: COMPLETED ·Phase: PHASE3
-
PeRsOnalising Treatment Of Diabetic Nephropathy:
NCT03509454 ·Status: COMPLETED
-
The Influence of the Thickening of Bowman's Capsule on the Clinical Prognosis of Patients With Diabetic Kidney Disease
NCT06049550 ·Status: UNKNOWN